Julie Morgan

403 total citations
16 papers, 253 citations indexed

About

Julie Morgan is a scholar working on Geriatrics and Gerontology, Cardiology and Cardiovascular Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Julie Morgan has authored 16 papers receiving a total of 253 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Geriatrics and Gerontology, 3 papers in Cardiology and Cardiovascular Medicine and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Julie Morgan's work include Pharmaceutical Practices and Patient Outcomes (5 papers), Palliative Care and End-of-Life Issues (3 papers) and Chronic Disease Management Strategies (2 papers). Julie Morgan is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (5 papers), Palliative Care and End-of-Life Issues (3 papers) and Chronic Disease Management Strategies (2 papers). Julie Morgan collaborates with scholars based in United Kingdom, Italy and Taiwan. Julie Morgan's co-authors include Mirko Baruscotti, Carlo Viscomi, Andrea Barbuti, Anna Moroni, Dario DiFrancesco, Claudia Altomare, Matthew Adams, Alison Blenkinsopp, Henry Chrystyn and David Wright and has published in prestigious journals such as European Respiratory Journal, Bioconjugate Chemistry and Pflügers Archiv - European Journal of Physiology.

In The Last Decade

Julie Morgan

16 papers receiving 243 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julie Morgan United Kingdom 10 83 82 68 56 28 16 253
Tamera D. Hughes United States 9 27 0.3× 111 1.4× 12 0.2× 11 0.2× 8 0.3× 30 268
Nicholas Freemantle United Kingdom 10 29 0.3× 9 0.1× 114 1.7× 22 0.4× 3 0.1× 20 360
Helen Tobin Ireland 9 62 0.7× 9 0.1× 19 0.3× 15 0.3× 16 0.6× 28 365
Michelle A. Bholat United States 7 10 0.1× 9 0.1× 14 0.2× 47 0.8× 14 0.5× 12 416
F Casadebaig France 9 19 0.2× 26 0.3× 27 0.4× 8 0.1× 1 0.0× 23 505
Peter Stott Qatar 9 20 0.2× 22 0.3× 15 0.2× 6 0.1× 4 0.1× 16 285
Krzysztof Buczkowski Poland 9 49 0.6× 2 0.0× 26 0.4× 25 0.4× 5 0.2× 39 320
Richard Duffett United Kingdom 10 8 0.1× 46 0.6× 28 0.4× 3 0.1× 5 0.2× 15 305
Susan Jongstra Netherlands 9 19 0.2× 34 0.4× 55 0.8× 4 0.1× 15 365
Samantha O’Connell United States 10 39 0.5× 14 0.2× 45 0.7× 3 0.1× 22 304

Countries citing papers authored by Julie Morgan

Since Specialization
Citations

This map shows the geographic impact of Julie Morgan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Morgan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Morgan more than expected).

Fields of papers citing papers by Julie Morgan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Morgan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Morgan. The network helps show where Julie Morgan may publish in the future.

Co-authorship network of co-authors of Julie Morgan

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Morgan. A scholar is included among the top collaborators of Julie Morgan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Morgan. Julie Morgan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Morgan, Julie, et al.. (2019). How timely is access to palliative care medicines in the community? A mixed methods study in a UK city. BMJ Open. 9(11). e029016–e029016. 10 indexed citations
2.
Harley, Dave, Julie Morgan, & Hannah Frith. (2018). Cyberpsychology as Everyday Digital Experience across the Lifespan. Palgrave Macmillan UK eBooks. 15 indexed citations
3.
Adams, Matthew & Julie Morgan. (2018). Mental Health Recovery and Nature: How Social and Personal Dynamics Are Important. Ecopsychology. 10(1). 44–52. 17 indexed citations
4.
Miller, Elizabeth, Julie Morgan, Alison Blenkinsopp, & Christina Wong. (2016). Are subcutaneous palliative medicines available and accessible: an out of hours (OOH) audit in sheffield. BMJ Supportive & Palliative Care. 6(3). 407.1–407. 1 indexed citations
5.
Armitage, Gerry, et al.. (2014). Custom and practice: A multi-center study of medicines reconciliation following admission in four acute hospitals in the UK. Research in Social and Administrative Pharmacy. 10(2). 355–368. 17 indexed citations
6.
Capstick, Toby, I. Clifton, Julie Morgan, Jonathan Silcock, & Alison Blenkinsopp. (2013). Inhaler technique: An unmet need in patients with difficult asthma?. European Respiratory Journal. 42(Suppl 57). P700–P700. 2 indexed citations
7.
Morgan, Julie, et al.. (2013). Communicating medication changes to community pharmacy post-discharge: the good, the bad, and the improvements. International Journal of Clinical Pharmacy. 35(5). 813–820. 40 indexed citations
8.
Armitage, Gerry, et al.. (2012). Is electronic discharge the answer. 2 indexed citations
9.
Morgan, Julie, et al.. (2008). Perceptions of Medicines Use Reviews - the views of community pharmcists within a West Yorkshire primary care trust.. Pharmaceutical journal/˜The œpharmaceutical journal. 281(7519). 303–305. 14 indexed citations
10.
Morgan, Julie, et al.. (2003). Development, implementation and cost‐effectiveness of a protocol for review of combination diuretic prescribing. British Journal of Clinical Pharmacology. 55(3). 317–320. 2 indexed citations
11.
Morgan, Julie, David Wright, & Henry Chrystyn. (2002). Pharmacoeconomic evaluation of a patient education letter aimed at reducing long-term prescribing of benzodiazepines.. Pharmacy World & Science. 24(6). 231–235. 21 indexed citations
12.
Minnock, Andrew, et al.. (2001). Sequence-Specific DNA Cleavage by Dipeptides Disubstituted with Chlorambucil and 2,6-Dimethoxyhydroquinone-3-mercaptoacetic Acid. Bioconjugate Chemistry. 12(6). 870–882. 11 indexed citations
13.
Moroni, Anna, Andrea Barbuti, Claudia Altomare, et al.. (2000). Kinetic and ionic properties of the human HCN2 pacemaker channel. Pflügers Archiv - European Journal of Physiology. 439(5). 618–626. 64 indexed citations
14.
Moroni, Anna, Andrea Barbuti, Claudia Altomare, et al.. (2000). Kinetic and ionic properties of the human HCN2 pacemaker channel. Pflügers Archiv - European Journal of Physiology. 439(5). 618–626. 28 indexed citations
15.
Morgan, Julie, et al.. (1999). Parliamentary scrutiny of defence. Journal of Legislative Studies. 5(1). 1–11. 3 indexed citations
16.
Corr, Charles A., et al.. (1991). International Work Group on Death, Dying and Bereavement. American Journal of Hospice and Palliative Medicine®. 8(2). 26–27. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026